Consistency and reproducibility of next‐generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens

Cytology Smears in the Era of Molecular Biomarkers in Non–Small Cell Lung Cancer: Doing More With Less

(2018) Maria D. Lozano et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

(2018) Neal I. Lindeman et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules

(2018) Marina N. Nikiforova et al.   CANCER

Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

(2018) Gregory P. Kalemkerian et al.   JOURNAL OF CLINICAL ONCOLOGY

The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics

(2018) Caterina Fumagalli et al.   JOURNAL OF CLINICAL PATHOLOGY

Results of the UK NEQAS for Molecular Genetics reference sample analysis

(2018) Susan D Richman et al.   JOURNAL OF CLINICAL PATHOLOGY

Clinical Implementation and Validation of Automated Human Genome Variation Society (HGVS) Nomenclature System for Next-Generation Sequencing–Based Assays for Cancer

(2018) Keith M. Callenberg et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping

(2018) Nicolas Guibert et al.   LUNG CANCER

Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling

(2018) Sinchita Roy-Chowdhuri et al.   MODERN PATHOLOGY

A Randomized Clinical Trial of Flex 19G Needles versus 22G Needles for Endobronchial Ultrasonography in Suspected Lung Cancer

(2018) Christophe Dooms et al.   RESPIRATION

Molecular testing of residual cytology samples: Rethink, reclaim, repurpose

(2018) Sinchita Roy-Chowdhuri   CANCER CYTOPATHOLOGY

Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples

(2018) Francesco Pepe et al.   JOURNAL OF CLINICAL PATHOLOGY

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer

(2017) Clara Mayo-de-las-Casas et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels

(2017) Lawrence J. Jennings et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting

(2017) Pasquale Pisapia et al.   Journal of Thoracic Disease

Preanalytic Variables in Cytology: Lessons Learned From Next-Generation Sequencing—The MD Anderson Experience

(2016) Sinchita Roy-Chowdhuri et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role forTERT,RB1,MEN1andKMT2D

(2016) Michele Simbolo et al.   JOURNAL OF PATHOLOGY

Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

(2016) Jacob J. Chabon et al.   Nature Communications

Multigene Clinical Mutational Profiling of Breast Carcinoma Using Next-Generation Sequencing

(2015) Sinchita Roy-Chowdhuri et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Massively parallel DNA sequencing from routinely processed cytological smears

(2015) Laure Piqueret-Stephan et al.   CANCER CYTOPATHOLOGY

Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective

(2015) E. Vigliar et al.   CYTOPATHOLOGY

Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing

(2015) Catherine I. Dumur et al.   Diagnostic Pathology

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology

(2015) Yuri E. Nikiforov et al.   THYROID

Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAFmutations

(2014) Michaela Angelika Ihle et al.   BMC CANCER

Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience

(2014) M. Bongiovanni et al.   CYTOPATHOLOGY

Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice?

(2014) E. Vigliar et al.   CYTOPATHOLOGY

High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas

(2014) Michele Simbolo et al.   VIRCHOWS ARCHIV

Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy)

(2013) Dario de Biase et al.   PLoS One

The Application of Molecular Diagnostic Studies Interrogating EGFR and KRAS Mutations to Stained Cytologic Smears of Lung Carcinoma

(2011) Bryan L. Betz et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Molecular cytopathology and flow cytometry: pre-analytical procedures matter

(2011) F. C. Schmitt   CYTOPATHOLOGY

Assessment of Epidermal Growth Factor Receptor and K-Ras Mutation Status in Cytological Stained Smears of Non-Small Cell Lung Cancer Patients: Correlation with Clinical Outcomes

(2011) M. D. Lozano et al.   ONCOLOGIST